Skip to main content


Firm News

Mayer Brown represents GW Pharmaceuticals plc on $101.1 million Nasdaq Global Market offering

9 January 2014
Mayer Brown represented the London-based GW Pharmaceuticals plc, a biopharmaceutical company, in a $101.1 million US public offering and listing of American Depositary Shares on the Nasdaq Global Market in an offering led by Morgan Stanley & Co. LLC and Cowen and Company, LLC. The transaction follows GW Pharmaceuticals’ US initial public offering in May 2013, on which Mayer Brown also represented the company.

The Mayer Brown team was led by Corporate & Securities partner David Bakst (New York) and included: Corporate & Securities – partner Richard Smith (London) and associate George Rudy (New York); Tax Transactions & Consulting – partners Jason Bazar (New York) and Sandy Bhogal (London) and associates Jared Goldberger (New York) and Benjamin Fryer (London); and Intellectual Property – partner Richard Assmus and associate Jonathan Kim (both Chicago).

Related Information

  • Related People
    Richard Smith
    T +44 20 3130 3849
    Jared B. Goldberger
    T +1 212 506 2421
    George E. Rudy
    T +1 212 506 2298
    Jason S. Bazar
    T +1 212 506 2323
    Ben Fryer
    T +44 20 3130 3552
    Richard M. Assmus
    T +1 312 701 8623
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.